Medical knowledgebase Encyclopedia portal Medvestnik.ru is the second release of the traditional series of related updates foreign clinical guidelines in cardiology for 2018 from the leading professional societies.
The review includes recommendations for antiplatelet therapy, developed by experts of the Canadian cardiological society (CCS) and the Canadian Association of interventional cardiology (CAIC). We are talking about changing therapy, in particular the transition from clopidogrel to ticagrelor or prasugrel, from prasugrel to ticagrelor and from ticagrelor to prasugrel. Furthermore, the authors give recommendations to colleagues practical advice on the dosage of medicines.
In addition, the review includes recommendations on the treatment of heart failure (HF) experts from the National heart Foundation of Australia and Cardiac society of Australia and New Zealand. In particular, options for the treatment of patients with heart failure and concomitant diseases. It is also about non-pharmacological management and surgical treatment of this group of patients.
Not less important component of the review were recommendations for screening of atrial fibrillation from the working group on disease prevention in the United States (USPSTF). Conclusion the USPSTF – insufficient data to recommend screening for atrial fibrillation with ECG in asymptomatic adults 65 years and older who have never been registered in atrial fibrillation.
Experts the USPSTF noted that assess the benets and harms of screening and clinical preventive “interventions” in healthy, asymptomatic people, while clinical management of patients is determined by clinical guidelines of professional societies.
Read more about the key provisions of the updated foreign clinical guidelines in cardiology for 2018, see “the school of the Clinician.”
All the news of the Russian and world medicine in our Telegram channel @MedicineNews.